Sangamo Therapeutics, Inc. (SGMO) Live Share Price, Invest From India

Sangamo Therapeutics, Inc. Stock Performance

as on November 6, 2025 at 11:39 pm IST

Day's Low
Day's High
$0.42
Day's Price Range
$0.51
$0.47
10.64%
Downside
8.51%
Upside
52 Week's Low
52 Week's High
$0.41
52-Week Price Range
$3.18
$0.47
12.53%
Downside
576.38%
Upside

Sangamo Therapeutics, Inc. share price movements today

Previous Close: $0.55
Open: $0.42
Volume: 8.8M
Day's Low - High: $0.42 - $0.51
52 Week Low - High: $0.41 - $3.18

Sangamo Therapeutics, Inc. Historical Returns

1 Month Return: -21.3 %
3 Month Return: + 3.81 %
1 Year Return: -77.73 %
3 Year Return: -84.8 %
5 Year Return: 0 %

Sangamo Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check Sangamo Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$173.7M

EPS (TTM)

-0.4067

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.69

Industry PE ratio

-0.8126129032258065

PEG Ratio

EBITDA

-58.3M

Revenue (TTM)

81.7M

Profit Margin

-77.48%

Return On Equity TTM

-292.47%

Sangamo Therapeutics, Inc. Stock Valuation

Track how Sangamo Therapeutics, Inc. P/E has moved over time to understand its valuation trends.

Sangamo Therapeutics, Inc. in the last 5 years

Overview
Trends

Lowest (-12.09x)

June 30, 2021

Industry (-0.81x)

November 6, 2025

Today (-0.69x)

November 6, 2025

Highest (-0.31x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -0.69x

Sangamo Therapeutics, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sangamo Therapeutics, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Sangamo Therapeutics, Inc.	BUY	$173.7M	NA	-0.69	-77.48%
Insmed Incorporated	BUY	$39.9B	473.78%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$55.9B	232.41%	1411.57	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$108.1B	89.3%	29.63	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$67.5B	11.45%	15.38	32.13%

Stock Returns calculator for Sangamo Therapeutics, Inc. Stock including INR - Dollar returns

The Sangamo Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Sangamo Therapeutics, Inc. investment value today

Current value as on today

₹24,064

Returns

₹75,936

(-75.94%)

Returns from Sangamo Therapeutics, Inc. Stock

₹80,972 (-80.97%)

Dollar Returns*

₹5,036 (+5.04%)

Analyst Recommendation on Sangamo Therapeutics, Inc. Stock

Based on 15 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 15 analysts, 66.67% of analysts recommend a 'BUY' rating for Sangamo Therapeutics, Inc.. Average target price of $4.1

Sangamo Therapeutics, Inc. Share Price Target

Get share price movements and forecasts by analysts on Sangamo Therapeutics, Inc..

What analysts predicted

88.54%UPSIDE

Target Price

$4.1

Current Price

$0.47

Analyzed by

15 Analysts

Target

$4.10

Sangamo Therapeutics, Inc. target price $4.1, a slight upside of 88.54% compared to current price of $0.47. According to 15 analysts rating.

Sangamo Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	157	6	9	2	0	0	49	7	6	18
Gross Profit	154	2	-2	0	-2	-23	47	7	6	18
Operating Income	135	-123	-106	-62	-51	-37	10	-25	-29	-17
EBITDA	24	-66	-56	-57	-44	-33	12	-23	-27	-18
Interest Expense	113	-	-	113	-	-	-	-	-	-
Depreciation	5	6	7	3	2	2	2	2	1	1
Income Before Tax	21	-120	-102	-60	-48	-36	10	-23	-30	-19
Income Tax Expense	0	-6	1	0	0	0	0	0	0	0
Net Income	21	-114	-104	-60	-49	-36	10	-23	-30	-19
Net Profit Margin	13.38%	-1675.29%	-1108.35%	-2952.74%	-10205.61%	-10148.31%	21.60%	-309.84%	-475.33%	-109.18%

Sangamo Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	39	19	36	84	102	118	110	111	176	57
Gross Profit	39	19	36	84	102	118	110	111	154	57
Operating Income	-46	-72	-56	-77	-105	-129	-183	-201	-274	-103
EBITDA	-45	-71	-54	-74	-95	-116	-165	-180	-240	-89
Interest Expense	-	-	-	-	-	22	22	9	-	-
Depreciation	-	-	1	2	9	13	17	20	24	9
Income Before Tax	-46	-71	-54	-68	-95	-120	-177	-191	-262	-98
Income Tax Expense	-5	0	-1	8	-19	0	0	0	-5	0
Net Income	-40	-71	-54	-68	-75	-121	-178	-192	-257	-97
Net Profit Margin	-102.94%	-369.58%	-149.23%	-80.91%	-74.02%	-102.48%	-161.06%	-172.76%	-146.30%	-169.45%

Sangamo Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-114	-104	-60	-49	-36	10	-23	-30	-19
Operating Cash Flow	-60	-47	-50	-48	-26	11	-3	-26	-18
Investing Cash Flow	42	37	37	35	0	0	1	-	0
Financing Cash Flow	6	0	0	22	0	0	6	8	28
Change in Cash	-11	-10	-11	8	-27	12	2	-16	13

Sangamo Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-71	-54	-68	-95	-121	-178	-192	-257	-97
Operating Cash Flow	-65	11	37	-144	169	-233	-223	-224	-67
Investing Cash Flow	18	-80	-178	-59	-271	248	59	153	37
Financing Cash Flow	0	97	231	142	153	32	84	14	28
Change in Cash	-47	27	90	-61	50	47	-78	-55	-3

Global Institutional Holdings in Sangamo Therapeutics, Inc.

Funds	Holdings
Vanguard Group Inc	3.11%
Wasatch Advisors LP	2.68%
Renaissance Technologies Corp	2.27%
BlackRock Inc	1.59%
Geode Capital Management, LLC	0.77%

See all

Insights on Sangamo Therapeutics, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 6.43M → 18.30M (in $), with an average increase of 64.8% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -30.59M → -19.98M (in $), with an average increase of 53.1% per quarter
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 926.8% return, outperforming this stock by 1011.6%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 156.5% return, outperforming this stock by 234.2%
NEGATIVE IMPACT
Price Dip
In the last 1 year, SGMO stock has moved down by -77.7%

About Sangamo Therapeutics, Inc.

for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.

Organisation	Sangamo Therapeutics, Inc.
Headquarters	501 Canal Blvd, Richmond, CA, United States, 94804
Industry	Health Technology
CEO	Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
E-voting on shares	Click here to vote

Key Management of Sangamo Therapeutics, Inc.

Name	Title
Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.	CEO, President & Director
Ms. Prathyusha Duraibabu CPA, M.B.A.	Interim Principal Financial Officer
Mr. Gregory Davis Ph.D.	Head of Research & Technology
Ms. Louise Wilkie	Head of Global Corporate Communications & Investor Relations
Mr. Phillip Ramsey	Chief Technical Officer
Mr. Scott B. Willoughby	Senior VP, Chief Legal Officer & Corporate Secretary
Dr. Nathalie Dubois-Stringfellow Ph.D.	Senior VP & Chief Development Officer
Mr. Nikunj Jain	VP of Finance, Corporate Controller & Principal Accounting Officer
Ms. Stephanie J. Seiler CLP	VP and Head of Business Development & Alliance Management
Mr. David Ojala	Scientist II - Discovery & Translational Research

FAQs

What is Sangamo Therapeutics, Inc. share price today?

Sangamo Therapeutics, Inc. share price today is $0.47 as on November 6, 2025 at 11:39 pm IST. Sangamo Therapeutics, Inc. share today touched a day high of $0.51 and a low of $0.42.

What is the 52 week high and 52 week low for Sangamo Therapeutics, Inc. share?

Sangamo Therapeutics, Inc. share touched a 52 week high of $3.18 on November 8, 2024 and a 52 week low of $0.41 on May 15, 2025. Sangamo Therapeutics, Inc. stock price today i.e. November 6, 2025 at 11:39 pm IST is trending at $0.47,which is 85.22% down from its 52 week high and 14.33% up from its 52 week low.

What is Sangamo Therapeutics, Inc.'s market capitalisation today?

Sangamo Therapeutics, Inc. market capitalisation is $0.00T as on November 6, 2025 at 11:39 pm IST.

How to invest in Sangamo Therapeutics, Inc. Stock (SGMO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sangamo Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sangamo Therapeutics, Inc. Shares that will get you 3.1915 shares as per Sangamo Therapeutics, Inc. share price of $0.47 per share as on November 6, 2025 at 11:39 pm IST.

What is the minimum amount required to buy Sangamo Therapeutics, Inc. Stock (SGMO) from India?

Indian investors can start investing in Sangamo Therapeutics, Inc. (SGMO) shares with as little as ₹88.566 or $1 (as of November 6, 2025 at 11:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹885.66 in Sangamo Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on November 6, 2025 at 11:40 pm IST). Based on Sangamo Therapeutics, Inc. share’s latest price of $0.47 as on November 6, 2025 at 11:39 pm IST, you will get 21.2766 shares of Sangamo Therapeutics, Inc.. Learn more about fractional shares .